How can vigilance for medical device software genuinely strengthen your certification process in critical care? For software vendors, healthcare CIOs and healthcare professionals facing the requirements of European Regulation MDR 2017/745, the challenge is considerable: balancing patient safety, regulatory compliance and innovation. You have come to the right place. This article explains how a robust vigilance system becomes a strategic asset for obtaining and maintaining CE marking for your digital health products.
What is vigilance for medical device software?
Vigilance for medical device software (known in France as matériovigilance) is the process of monitoring, identifying and reporting incidents related to its use after it has been placed on the market. Overseen by the ANSM (France’s national medicines and medical devices regulator) and European Regulation 2017/745, it aims to ensure the safety of patients and users through rigorous handling of adverse events. Read on to discover how this process structures compliance and speeds up certification.
Vigilance: an essential regulatory requirement under the MDR
European Regulation 2017/745 (MDR) requires every medical device manufacturer, including software manufacturers, to set up a rigorous post-market surveillance system. Vigilance is its central pillar and an essential requirement for obtaining CE marking.
The manufacturer’s key obligations
In terms of vigilance, the manufacturer must in particular:
- Identify and analyse every incident related to a medical device (display error, missed alert, critical malfunction).
- Report serious incidents to the ANSM via the dedicated portal.
- Implement documented corrective and preventive actions.
- Keep the technical documentation and Periodic Safety Update Reports (PSURs) up to date.
Without a structured vigilance system, it is impossible to meet the MDR’s continuous surveillance requirements. For a digital tool used in critical care, where every piece of data processed can influence a life-or-death clinical decision, this rigour is non-negotiable.
Strengthening risk management and control throughout the lifecycle
Vigilance makes it possible to detect risks that were not anticipated during the design phase. For a software vendor operating in critical care, where use scenarios can be unpredictable, this monitoring is crucial.
From field data to continuous improvement
Vigilance reports submitted by healthcare professionals and local vigilance officers (correspondants locaux de matériovigilance) feed a continuous improvement loop:
- Identifying real-world incidents: every reported case enriches the risk analysis (dose calculation error, delayed alert, interface anomaly).
- Updating the risk management file: the information collected makes it possible to revise processes and strengthen product safety.
- Anticipating trends: statistical analysis of the data helps detect weak signals before they become critical.
This approach turns vigilance into a genuine quality management tool, essential for anaesthetists, ICU physicians and critical care nurses who rely on this healthcare software every day.
Demonstrating responsiveness to notified bodies
To obtain and maintain medical device certification, the vendor must prove that it has processes in place to monitor, evaluate and continuously improve its digital tool.
Traceability and documentation: a dual requirement
Vigilance plays a central role in:
- Demonstrating tangible responsiveness to incidents, with rapid implementation of corrective actions.
- Documenting every action (CAPA – Corrective and Preventive Actions) to ensure full traceability.
- Preparing for notified body audits by providing a structured history of reports.
Producing mandatory reports in full compliance
The MDR requires the regular production of key documents whose quality depends directly on how robust the vigilance organisation is.
Deliverables expected by health authorities
The main reports to be provided include:
- The PSUR (Periodic Safety Update Report) for Class IIa, IIb and III devices, updated at intervals that depend on the product class.
- Serious incident reports, submitted to the ANSM within the regulatory deadlines.
- The Summary of Safety and Clinical Performance (SSCP), published in the European Eudamed database.
A well-structured vigilance system makes it easier to collect, manage and publish this data. For healthcare CIOs responsible for deploying software in critical care, this documentary rigour is a guarantee of reliability and a compelling argument in hospital tenders.
Making vigilance a driver of responsible innovation
Beyond the obligation, vigilance for medical device software becomes a genuine driver of innovation for vendors who know how to make the most of it.
From field feedback to clinical software evolution
By identifying issues quickly through user feedback, the vendor can:
- Iterate faster on its products, incorporating feedback from healthcare professionals into targeted updates.
- Design new features that take account of real-world use cases and observed incidents.
- Strengthen dialogue with healthcare facilities, anaesthetists, ICU physicians and critical care nurses.
This virtuous circle turns a regulatory constraint into a competitive advantage. A vendor that masters vigilance becomes more agile while meeting MDR requirements – an essential balance in a fast-growing market.
You now know how vigilance for digital medical devices tangibly strengthens your certification process in critical care. Do not underestimate the power of this lever: when well structured, it turns a regulatory obligation into a genuine strategic asset for the safety of your patients and the long-term viability of your business.
About Bow Medical
A software vendor for more than 20 years, we support healthcare professionals in transforming the critical care pathway. This French company, a European leader in its field, has made improving and securing critical care its core mission.
Bow Medical’s expertise focuses on one specific challenge: digitising critical care. This particular segment of the electronic patient record (EPR) requires in-depth knowledge of clinical practices and operational constraints. The Diane platform, the product of this expertise, delivers real added value in terms of performance for users, reliability, safety and optimisation of clinicians’ time.
The figures speak for themselves: more than 450 healthcare facilities trust our software for anaesthesia and ICU care. Diane Consult handles 5 million anaesthesia consultations a year, representing around 70% of digitised consultations in France. In operating theatres, 3,000 rooms rely on Diane Op, while more than 1,200 ICU beds use Diane Rea to optimise the care pathway for the most critically ill patients.
